Rapigen is striving to develop highly innovative products which aims to offer customer satisfaction in the rapid diagnosis kit industry to increase product sensitivity, specificity, and reproducibility by utilizing the optimized black gold technology accumulated over 20 years of research and development.

Rapigen’s Biocredit Covid-19 Home Test Kit was the first self-test kit to receive official authorization from the Korean Ministry of Food and Drug Safety (MFDS) recognized for its high quality, and continues to expand the global market presence based on mutual trust with local partners in more than 50 countries.

We will continue to ascend forward to develop and provide the most trusted in-vitro diagnostic products in the domestic and overseas life science fields based on our founding spirit of “No compromise in quality.”

Rapigen promises to grow as a global leader contributing to the healthier and prosperity of humankind through rapid and accurate diagnosis of diseases.

CEO  ｜  Jae Ku Park, Ph.D.